Endocrine disruptor assessment list

Endocrine disruptor assessment list

Endocrine disruptor assessment list

ECHA’s endocrine disruptor (ED) assessment list includes the substances undergoing an ED assessment that have been brought for discussion to ECHA’s ED Expert Group.

Explanatory note

Inclusion in the list means that an informal hazard assessment for endocrine-disrupting properties either is under development or has been completed since February 2013.

For each substance, the table shows the assessing or evaluating Member State (submitter), the outcome from the assessment, and the date of the latest update to the list entry.

Other process details and hazard assessment outcome documents are also available and can be accessed through the ‘Details’ icon.

One possible outcome of such an assessment is that a substance is considered not to have ED properties.

If the outcome is that the substance is considered to have ED properties, confirmation through the formal risk management and decision-making processes under is needed before any regulatory action can be taken due to these properties.

The intentions of authorities to submit a dossier to the formal REACH and CLP processes are notified through the Registry of Intentions. All biocidal active substances have to undergo a formal ED assessment. You can see the status of biocides assessments on the Biocidal Active Substances page.

Disclaimer

The information and views set out in the ED assessment list and in the hazard assessment outcome documents are those of the evaluating authority and do not necessarily reflect the position or opinion of the other Member States or ECHA. Neither ECHA nor the evaluating authority nor any person acting on either of their behalves may be held liable for the use, which may be made of the information contained therein. Statements made or information contained in the documents are without prejudice to any formal regulatory activities that ECHA or the Member States may initiate at a later stage. ED assessments and their outcomes are compiled on the basis of information available by the date of the publication of the document.

Last updated 04 April 2024. Database contains 119 unique substances/entries.
Filter the list
Date of hazard assessment:
Date of intention:
Latest update:

The List does not contain any Substances.
 
602-782-4
122453-73-0
Portugal
Under development
Under development (BPR)
04-Apr-2024
Details
201-280-9
80-46-6
Germany
Concluded
ED ENV
inconclusive
19-Mar-2024
Details
614-054-3
67375-30-8
Under development
Under development (BPR)
19-Mar-2024
Details
203-236-4
104-78-9
Under development
Under development (other)
19-Mar-2024
Details
270-877-4
68479-98-1
Denmark
Concluded
inconclusive
22-Feb-2024
Details
202-394-1
95-14-7
Germany
Concluded
ED ENV
22-Feb-2024
Details
202-679-0
98-54-4
Germany
Concluded
ED ENV
inconclusive
22-Feb-2024
Details
259-978-4
56073-07-5
Finland
Under development
Under development (BPR)
16-Jan-2024
Details
629-661-9
83834-59-7
Germany
Concluded
inconclusive
23-Nov-2023
Details
226-378-9
5384-21-4
Germany
Under development
Under development (other)
16-Oct-2023
Details
201-545-9
84-61-7
Sweden
Concluded
ED ENV
04-Oct-2023
Details
300-340-2
93925-38-3
Sweden
Under development under SEV
Under development (SEV)
25-Sep-2023
Details
200-712-3
69-72-7
Netherlands
Under development
Under development (BPR)
15-Sep-2023
Details
811-718-6
86347-14-0
Norway
Under development
Under development (BPR)
15-Sep-2023
Details
202-307-7
94-13-3
Belgium
Concluded
ED ENV
01-Sep-2023
Details
246-678-3
25155-25-3
Netherlands
Under development
Under development (SEV)
14-Aug-2023
Details
212-791-1
870-08-6
Austria
Under development under SEV
Under development (SEV)
19-Jul-2023
Details
308-662-5
98171-53-0
France
Under development under SEV
Under development (SEV)
19-Jul-2023
Details
204-112-2
115-86-6
France
Concluded
ED ENV
12-Jun-2023
Details
218-407-9
2144-53-8
Germany
Concluded
ED ENV
12-Jun-2023
Details
241-527-8
17527-29-6
Germany
Concluded
ED ENV
12-Jun-2023
Details
262-872-0
61617-00-3
Germany
Concluded
ED ENV
12-Jun-2023
Details
258-904-8
53988-10-6
Germany
Concluded
ED ENV
12-Jun-2023
Details
201-250-5
80-09-1
Belgium
Concluded
ED ENV
ED HH
04-May-2023
Details
701-394-3
1782069-81-1
Germany
Concluded
inconclusive
12-Apr-2023
Details
807-935-0
1244733-77-4
Denmark
Under development under SEV
Under development (SEV)
03-Apr-2023
Details
701-171-0
-
Germany
Concluded
ED ENV
20-Mar-2023
Details
262-975-0
61788-44-1
Germany
Concluded
ED ENV
20-Mar-2023
Details
200-143-0
52-51-7
Spain
Under development
Under development (BPR)
15-Mar-2023
Details
701-337-2
-
France
Postponed
postponed
23-Jan-2023
Details
219-006-1
2312-35-8
Netherlands
Concluded
postponed
23-Jan-2023
Details
224-208-8
4247-02-3
Denmark
Concluded
ED HH
23-Jan-2023
Details
1 - 4.5 moles propoxylated
500-097-4
37353-75-6
Denmark
Concluded
postponed
23-Jan-2023
Details
428-970-4
13595-25-0
Belgium
Concluded
postponed
23-Jan-2023
Details
627-872-0
1514-82-5
Spain
Concluded
postponed
23-Jan-2023
Details
206-022-9
288-88-0
Belgium
Concluded
postponed
23-Jan-2023
Details
244-617-5
21850-44-2
Germany
Concluded
postponed
23-Jan-2023
Details
306-832-3
97416-84-7
Germany
Concluded
postponed
23-Jan-2023
Details
206-354-4
330-54-1
Denmark
Under development
Under development (BPR)
20-Oct-2022
Details
203-377-1
106-24-1
France
Under development
Under development (BPR)
16-Sep-2022
Details
204-442-7
121-00-6
France
Under development under SEV
Under development (SEV)
18-Aug-2022
Details
-
-
Denmark
Concluded
ED HH
04-Aug-2022
Details
274-581-6
70356-09-1
Germany
Under development under SEV
Under development (SEV)
02-Aug-2022
Details
201-126-0
78-59-1
France
Postponed
postponed
26-Jul-2022
Details
229-962-1
6864-37-5
Germany
Concluded
not ED
27-Jun-2022
Details
262-104-4
60207-90-1
Finland
Concluded
ED ENV
ED HH
23-May-2022
Details
200-843-6
75-15-0
France
Concluded
not ED
18-May-2022
Details
216-823-5
1675-54-3
Denmark
Concluded
inconclusive
15-Mar-2022
Details
216-653-1
1634-04-4
France
Concluded
inconclusive
10-Mar-2022
Details
201-289-8
80-54-6
Sweden
Concluded
inconclusive
10-Mar-2022
Details

Export search results to: